Effects of tetrazanbigen on the protein expression in human hepatocellular carcinoma cell line QGY-7701

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 29, Issue 3, 2009, Pages 304-308

  Yuan, Yonghua ^a,b   Li, Wei ^a   Li, Longjiang ^a   Yang, Xiaolan ^a   Gu, Rong ^b   Liu, Huabo ^a   Huang, Kaishun ^a   Yu, Yu ^a  

^a School of Pharmacy   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Antitumor; Lipid metabolism; Proteomics; Tetrazanbigen

Indexed keywords

ANTINEOPLASTIC AGENT; AZO COMPOUND; GONANE DERIVATIVE; PROTEIN; PROTEOME; TETRAZANBIGEN;

ARTICLE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; AZO COMPOUNDS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GONANES; HUMANS; LIVER NEOPLASMS; PROTEINS; PROTEOME;

EID: 70349684657     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-009-0308-9     Document Type: Article

References (19)

1. Yu Y. Preparation and use of a kind of azagonane compound. Chinese patent (Chinese), 1996. CN1124251
2. L.J. Li Y. Yu W.X. Tang, et al. 2005 Effects of TNBG on the proliferation and apoptosis of human hepatocellular carcinoma cell line QGY-7701 J Sichuan Univ (Med Sci) (Chinese) 36 372 374
3. L.J. Li X.L. Yang Y.H. Yuan, et al. 2006 Changes of gene expression of human hepatocellular carcinoma cell line QGY-7701 induced by tetrazanbigen Acta Academiae Medicinae Militaris Tertiae (Chinese) 28 151 153
4. Y.Y. Hwang M.D. Li 2006 Protein differentially expressed in response to nicotine in five rat brain regions: Identification using a 2-DE/MS-based proteomics approach Proteomics 6 3138 3153
5. D. Jiang W. Ying Y. Lu, et al. 2003 Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis Proteomics 3 724 737
6. L.S. Ramagli L.V. Rodriguez 1985 Quantitation of microgram amounts of protein in two-dimensional polyacrylamide gel electrophoresis sample buffe Electrophoresis 6 559 563
7. V. Neuhoff N. Arold D. Taube, et al. 1988 Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitity using Coomassie brilliant blue G-250 and R-250 Electrophoresis 9 255 262
8. C. Gerner U. Frohwein J. Gotzmann, et al. 2000 The Fas-induced apoptosis analyzed by high throughput proteome analysis J Biol Chem 275 50 39018 39026
9. M.J. Page B. Amess C. Rohlff, et al. 1999 Proteomics: A major new technology for the drug discovery process Drug Discov Today 4 55 62
10. R. de Crom R. van Haperen R. Janssens, et al. 1999 Grp96/Grp94 is a putative high density lipoprotein-binding protein in liver Biochim Biophys Acta 1437 3 378 392
11. H. Lan M.E. Rabaglia K.L. Schueler, et al. 2004 Distinguishing covariation from causation in diabetes:a lesson from the protein disulfide isomerase mRNA abundance trait Diabetes 53 240 244
12. J.R. Wetterau K.A. Combs L.R. et. a1. Mclean 1991 Protein disulfide isomerase appears necessary to maintain the catalytically active structure of the microsomal triglyceride transfer protein Biochemistry 30 40 9728 9735
13. D. Eberle B. Hegarty P. et. a1. Bossard 2004 SREBP transcription factors: master regulators of lipid homeostasis Biochimie 86 11 839 848
14. G. Ccombs G. Westrop P. et. a1. Suehan 2004 The Amitechondriate eukaryote triehomonas vaginalis contains a divergent thioredoxin-1inked peroxiredoxin antioxidant system J Bio Chem 279 7 5249 5256
15. N.H. Beyer P. Roepstorf K. et. a1. Hammer 2003 Protcome analysis of the purine stimulon from Lactecaceus lactis Proteomics 3 5 786 797
16. B.H. Li X.F. Ma Y. Wang, et al. 2005 Structure-activity relationship of polyphenols that inhib it Fatty Acid Synthase J Biochem (Tokyo) 138 679 685
17. N. Scaglia J.M. Caviglia R.A. Igal 2005 High stearoyl-CoA desaturase protein and activity levels in simian virus 40 transformed-human lung fibroblasts Biochim Biophys Acta 1687 141 151
18. J.L. Goldstein M.S. Brown 1990 Regulation of the mevalonate pathway Nature 343 425 430
19. M. Jakobisiak J. Golab 2003 Potential antitumor effects of statins (Review) Int J Oncol 23 1055 1069